Borosil Scientific Limited Business Intelligence Report
Borosil Scientific Limited Business Intelligence Report
Quality Scores
Latest Quarterly Earnings Summary
Loading latest quarter…
AI Summary
Borosil Scientific Limited, a key constituent of the Borosil Group, is a specialized player in the scientific and laboratory glassware market. The business has successfully transitioned through a restructuring phase, maintaining its leadership in QC-intensive sectors like pharmaceuticals and biotechnology. Financially, the company exhibits a stable growth trajectory with revenues increasing from ₹392 Cr to ₹467 Cr over the reported three-year cycle. While operating margins are healthy at 13%, the return on equity remains relatively modest at approximately 9.5-10%. The company maintains a…
Key Changes in FY2026
The business has evolved from a traditional glassware manufacturer into a specialized supplier for microbiology, biotechnology, and pharmaceutical quality control. A significant strategic shift occurred between FY24 and FY26, evidenced by a steady increase in sales from ₹392 Cr to ₹467 Cr and a diversification into tubular glass vials and ampoules. The company is moving up the value chain by targeting high-margin pharmaceutical customers, who now form a significant portion of the scientific customer mix. Digital transformation and increased SKU complexity suggest an evolution toward a 'one-stop-shop' for laboratory needs.
Management Commentary
The management team, deeply rooted in the Borosil Group's long heritage since 1962, demonstrates high domain expertise in the scientific glassware niche. Communication is transparent regarding the company's market position in domestic laboratory glassware and its reliance on the pharmaceutical sector. Recent management changes, such as the transition of Sharad Tiwari, appear to be internal reorganizations rather than signs of instability. The promoter holding is strong and increasing, moving from 67.8% to 68.27% over recent quarters, which signals high management conviction. However, the lack of dividend distribution despite a 'debt-free' status suggests a very conservative or perhaps cautious management outlook. Overall management quality is rated high due to the group's legacy and lack…
Financial Highlights
The business demonstrates steady top-line growth, with a TTM revenue increase of 8% and a notable profit surge of 50%, albeit from a lower base during the restructuring period. Operating Profit Margins (OPM) have shown resilience, improving from 12% in FY24 to 13% in FY26. The bottom-line quality is bolstered by consistent profits, although the tax rate has shown significant volatility ranging from 19% to 34%. Capital efficiency, measured by ROCE, has improved from 10% to 12% over three years, indicating better utilization of the capital base. The presence of significant non-operating income in FY25 (₹8 Cr) slightly inflated the profit before tax for that period. Overall, the financial profile is one of a stable industrial entity with moderate growth and high asset backing.
Major Opportunities
- Virtually debt-free balance sheet
- Consistent double-digit operating margins
- Positive free cash flow generation
Major Risks
- High inventory holding period (226 days)
- Low historical Return on Equity (ROE)
- Zero dividend payout despite profitability
About Borosil Scientific Limited's Annual Report & Financial Performance
The latest Borosil Scientific Limited annual report (FY2026) is the company's flagship annual disclosure, filed with NSE / BSE. It covers the full-year business review, management discussion & analysis, audited financial statements, the director's report, the corporate governance and auditor's reports, risk factors, capital allocation, subsidiaries, related-party transactions and ESG initiatives. This Business Intelligence Hub consolidates the official filings with AI-generated financial analysis so investors can see how revenue, operating margin, cash flow quality, capex, dividends, net debt and management outlook have changed — without reading the entire filing.
What this Borosil Scientific Limited research covers
- Fundamental & business analysis
- Financial statements & performance
- Management commentary & discussion
- Corporate governance & auditor report
- Cash flow analysis & capital allocation
- Valuation analysis & business quality
- Growth analysis & competitive position
- Risk, SWOT & moat analysis
- Quarterly earnings & conference-call summary
- Sector, industry & peer comparison
- Latest official company filings
- Business outlook & long-term growth
Borosil Scientific Limited — Frequently Asked Questions
Explore more Borosil Scientific Limited research
AI Top Insights — Premium
Unlock deeper AI Top Insights, advanced comparisons, downloadable reports and premium features.